SPOTLIGHT: Lymphoma drugs often avoided


Only a fraction of the patients who could benefit from lymphoma drugs like Bexxar and Zevalin actually get them, largely because doctors get reimbursed on other therapies or are reluctant to refer patients to competing academic centers. Report